This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Simon Mitchell
mitchell.science
did:plc:r6mjbevbvxl56zgvuwwd2igk
Diffuse Large B-cell Lymphoma (DLBCL) has lots of BCL2 and NF-kB. Both drive poor prognosis.
Lots of people have tried inhibiting these. But NF-kB is 2 pathways, 5 proteins, and there are many BCL2-family proteins.
We found previously (https://doi.org/10.3389/fonc.2023.1181660), each DLBCL has a unique "fingerprint".
2024-12-06T18:18:51.707Z